Stiles Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$612K Sell
2,814
-84
-3% -$18.6K 0.19% 109
2025
Q4
$662K Sell
2,898
-49
-2% -$11.2K 0.2% 104
2025
Q3
$682K Sell
2,947
-330
-10% -$67.2K 0.22% 104
2025
Q2
$608K Sell
3,277
-90
-3% -$16.7K 0.21% 106
2025
Q1
$706K Sell
3,367
-809
-19% -$157K 0.27% 91
2024
Q4
$742K Sell
4,176
-1,045
-20% -$192K 0.27% 89
2024
Q3
$1.03M Sell
5,221
-681
-12% -$127K 0.36% 79
2024
Q2
$1.01M Sell
5,902
-431
-7% -$71.4K 0.39% 76
2024
Q1
$1.15M Sell
6,333
-811
-11% -$140K 0.46% 72
2023
Q4
$1.11M Sell
7,144
-1,537
-18% -$224K 0.5% 67
2023
Q3
$1.29M Sell
8,681
-2,469
-22% -$362K 0.67% 50
2023
Q2
$1.5M Buy
11,150
+1,480
+15% +$217K 0.75% 44
2023
Q1
$1.54M Buy
9,670
+62
+0.6% +$9.48K 0.83% 36
2022
Q4
$1.55M Buy
9,608
+401
+4% +$61.5K 0.89% 32
2022
Q3
$1.24M Buy
9,207
+3,102
+51% +$445K 0.75% 42
2022
Q2
$935K Buy
6,105
+355
+6% +$54.2K 0.56% 57
2022
Q1
$932K Buy
5,750
+180
+3% +$26.1K 0.47% 62
2021
Q4
$754K Buy
+5,570
New +$658K 0.36% 80

Other funds holding ABBV

Stiles Financial Services's ABBV Position: Q1 2026 in Review

Stiles Financial Services reduced its AbbVie (ABBV) stake by 2.9% in Q1 2026, selling an estimated $18.6K and leaving 2,814 shares worth $612K. The position accounts for 0.19% of the portfolio, ranked #109.

Stiles Financial Services first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.55M in Q4 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Stiles Financial Services held 2,814 shares of AbbVie worth $612K as of Q1 2026.
  • Stiles Financial Services sold 84 AbbVie shares in Q1 2026, an estimated $18.6K.
  • AbbVie made up 0.19% of Stiles Financial Services's portfolio in Q1 2026, its #109 holding.
  • Stiles Financial Services first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Stiles Financial Services's AbbVie position peaked at $1.55M in Q4 2022.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Stiles Financial Services's 13F filing for Q1 2026, filed 30 Apr 2026.